Français
Español
English
Portuguese
Good News Israel presents success for treatment of back pain; sealing up after surgery and much more.
By: Michael Ordman
ISRAEL’S MEDICAL ACHIEVEMENTS
Success for treatment of back pain
Israel’s Nervomatrix has reported success from independent controlled trials of its hyper-stimulation pulse device for treating lower back pain. The study on 28 patients at Belgian’s Free University of Brussels obtained significant pain relief after 4 treatments compared to a control group.
http://www.globes.co.il/en/article-nervomatrix-reports-back-pain-system-trial-success-1001059763
Protection against future flu strains
Israel’s BiondVax has published independent tests of trials showing that its M-001 Universal Flu vaccinations given 3 years ago have protected patients from flu strains that only came into existence well after the vaccine was administered.
Sealing up after surgery
Israel’s LifeBond has developed LifeSeal – a sealant to greatly reduce surgical leaks, which are associated with potential infections and other serious complications, risking the lives of hundreds of thousands every year. LifeBond has just raised $27 million of funding.
2015 WEF Technology Pioneers
Three Israeli companies were chosen by the World Economic Forum (WEF) in its 2015 list of 14 Technology Pioneers in the Life Science and Health category. ElMindA’s Brain Network Activation identifies brain damage. Consumer Physics’s SCIO is a chemical analyzer. Novocure uses electric fields to treat solid tumors.
http://www.israel21c.org/elminda-consumer-physics-novocure-awarded-technology-pioneer-by-world-body/
Robotic needle steering
Israeli startup XACT Robotics developed a robotic system for needle steering, for use in biopsies and ablations, or to inject medications in specific areas of the body. The first application of XACT’s technology will be for biopsies in lung tissue. XACT has just raised $5 million to fund US trials.
http://www.globes.co.il/en/article-xact-robotics-raises-5m-1001059641
Fast track for Muscular Dystrophy treatment
The US FDA has given fast track approval to Israel’s BioBlast for its Cabaletta treatment for two rare and currently untreatable conditions – oculopharyngeal muscular dystrophy (OPMD) and spinocerebellar ataxia type 3 (SCA3).
http://www.israel21c.org/drug-for-rare-muscular-dystrophy-fast-tracked/
Click here for all of this week’s Good News from Israel.
Do You Love Israel? Make a Donation - Show Your Support!
Donate to vital charities that help protect Israeli citizens and inspire millions around the world to support Israel too!
Now more than ever, Israel needs your help to fight and win the war -- including on the battlefield of public opinion.
Antisemitism, anti-Israel bias and boycotts are out of control. Israel's enemies are inciting terror and violence against innocent Israelis and Jews around the world. Help us fight back!
